You just read:

CStone submits new drug application for the targeted therapy avapritinib in Taiwan for the treatment of adults with advanced PDGFRA exon 18 mutant gastrointestinal stromal tumor

News provided by

CStone Pharmaceuticals

Mar 27, 2020, 02:02 ET